|

Efficacy of Written Versus Video Patient Education Materials for Postmastectomy Breast Reconstruction

RECRUITINGN/ASponsored by University of California, San Francisco
Actively Recruiting
PhaseN/A
SponsorUniversity of California, San Francisco
Started2026-06-06
Est. completion2028-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This is a prospective, randomized controlled trial evaluating the comparative efficacy of written, video, and combined written and video patient education materials relative to no supplemental education for University of California, San Francisco (UCSF) patients presenting for post-mastectomy breast reconstruction consultation.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults aged 18 or older
* Presenting as a new patient to the UCSF plastic surgery breast reconstruction clinic
* Considering mastectomy, including:
* \- Therapeutic mastectomy in the setting of a breast cancer diagnosis
* \- Prophylactic mastectomy in the setting of a confirmed high-risk genetic variant
* \- Staged procedures, including delayed mastectomy with initial reduction
* Participants who are undecided between lumpectomy and mastectomy

Exclusion Criteria:

* Established patients returning for follow-up, in order to minimize confounding variables of individual surgeon education style on outcome measures
* Participants who are primarily considering lumpectomy or oncoplastic reduction at the time of their visit
* Non-English speakers, as educational materials are currently available in English only

Conditions2

AnxietyBreast Surgery

Locations1 site

University of California, San Francisco
Reta Behnam-Hanona, BA877-827-3222Reta.Behnam@ucsf.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.